RGLS

Regulus Therapeutics
RGLS

Overview Fund Activity
Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

28 hedge funds and large institutions have $3.97M invested in Regulus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
4
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
1
EcoR1 Capital
California
$870K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$33K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$238K
4
MIG
4
McGuire Investment Group
Rhode Island
$9K
5
Simplex Trading
5
Simplex Trading
Illinois
$7K

Top Sellers

1
BI
1
BVF Inc
California
$734K
2
CH
2
CVI Holdings
Delaware
$129K
3
Rockefeller Capital Management
3
Rockefeller Capital Management
New York
$39K
4
UBS Group
4
UBS Group
Switzerland
$0
5
WS
5
Wedbush Securities
California
$10K
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$0 100 – –
SIM
27
Sonora Investment Management
Arizona
$0 16 – –
IA
28
IFP Advisors
Florida
– – – –
SPIA
29
Steward Partners Investment Advisory
New York
$0 83 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
BCM
31
Bourgeon Capital Management
Connecticut
$0 317 – –
Bank of America
32
Bank of America
North Carolina
$0 638 +638 New
1
2